Cargando…

Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene

Lung cancer is a type of cancer with higher morbidity and mortality. In spite of the impressive response rates of nab-paclitaxel (nab-PTX) or programmed cell death-1 (PD-1) and its ligand inhibitors, the effective treatment remains limited. Currently, alternative strategies aim at drug combination o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Tang, Zhijia, Guo, Xi, Wang, Yunxia, Zhou, Yuhong, Cai, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381811/ https://www.ncbi.nlm.nih.gov/pubmed/35992834 http://dx.doi.org/10.3389/fonc.2022.933646

Ejemplares similares

Corrigendum: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene
por: Zhang, Jun, et al.
Publicado: (2023)

Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel
por: Li, Xiaocheng, et al.
Publicado: (2022)

Serpinc1 Acts as a Tumor Suppressor in Hepatocellular Carcinoma Through Inducing Apoptosis and Blocking Macrophage Polarization in an Ubiquitin-Proteasome Manner
por: Xu, Dacai, et al.
Publicado: (2021)

Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2020)

Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer
por: Okuno, Keisuke, et al.
Publicado: (2022)

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
por: Lin, Ke, et al.
Publicado: (2020)

Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer
por: Okuno, Keisuke, et al.
Publicado: (2022)

SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
por: Jin, Qianxu, et al.
Publicado: (2022)

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022)

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
por: Carnero, Amancio, et al.
Publicado: (2014)

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
por: Xiang, Yubo, et al.
Publicado: (2023)

Utility of the SERPINC1 Gene Test in Ischemic Stroke Patients With Antithrombin Deficiency
por: Kim, Seondeuk, et al.
Publicado: (2022)

Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency
por: Wang, Han-lu, et al.
Publicado: (2023)

LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells
por: Wang, Zifeng, et al.
Publicado: (2019)

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
por: Cintas, Célia, et al.
Publicado: (2018)

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
por: Ceelen, Wim, et al.
Publicado: (2022)

Mitochondrial Respiration Inhibition Suppresses Papillary Thyroid Carcinoma Via PI3K/Akt/FoxO1/Cyclin D1 Pathway
por: Chen, Bojie, et al.
Publicado: (2022)

PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series
por: Tan, Sirui, et al.
Publicado: (2022)

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
por: Yu, Xi, et al.
Publicado: (2021)

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
por: Roshini, Arivazhagan, et al.
Publicado: (2022)

PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality
por: Yakovlev, Vasily A., et al.
Publicado: (2023)

Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
por: Kampo, Sylvanus, et al.
Publicado: (2019)

YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling
por: Fan, Xiaoqin, et al.
Publicado: (2021)

Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015)

Case report: A case of new mutation in SERPINC1 leading to thrombotic microangiopathy
por: Li, Bing, et al.
Publicado: (2023)

CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
por: Zheng, Zaosong, et al.
Publicado: (2019)

Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study
por: Guo, Qian, et al.
Publicado: (2019)

Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
por: Liu, Huijuan, et al.
Publicado: (2021)

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
por: Lin, Weimin, et al.
Publicado: (2018)

PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world study
por: Cheng, Daoan, et al.
Publicado: (2023)

A Commentary on “PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer”
por: Di Virgilio, Francesco
Publicado: (2015)

Corrigendum: Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
por: Kampo, Sylvanus, et al.
Publicado: (2021)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway
por: Zhang, Daoyu, et al.
Publicado: (2020)

LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma
por: Peng, Chenghao, et al.
Publicado: (2021)

Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway
por: Cheng, Yi, et al.
Publicado: (2021)

Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer
por: Deng, Xiangying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_26c4kb269c4cgqombjdts5pgq7